Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns OPHC Q1 2026 Earnings EPS Misses Estimates by 1475 CALX Q1 2026 Earnings EPS Matches Estimates Amid Broadband Platform Momentum CANF Q4 2023 Earnings Narrower Loss Surprises Amid PreRevenue Stage SNTI Q1 2026 Earnings NarrowerThanExpected Loss Cautiously Lifts Shares PSX Q1 2026 Earnings Strong Earnings Surprise Driven by Improved Refining Margins